1503P Prevalence and clinical characteristics of metastatic synovial sarcoma (mSS) patients with tumours expressing NY-ESO-1 antigen (NY+) and who are HLA-A*02:01, *02:05 or *02:06 allele positive (HLA+): Cohort study from the French sarcoma group
Armelle Dufresne, Alexandra Meurgey, Sylvie Chabaud, Julien Bollard, Myriam Jean‐Denis, Laurie Tonon, Nicolas Gadot, Charlotte Neve, Jean Yves Blay, Mary Woessner, Erika Klohe, T. Thayaparan, Kristin Blouch, Ioanna Eleftheriadou, Michael J. Nathenson, Shibani Pokras (2022). 1503P Prevalence and clinical characteristics of metastatic synovial sarcoma (mSS) patients with tumours expressing NY-ESO-1 antigen (NY+) and who are HLA-A*02:01, *02:05 or *02:06 allele positive (HLA+): Cohort study from the French sarcoma group. , 33, DOI: https://doi.org/10.1016/j.annonc.2022.07.1606.
